National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
ipilimumab (ih-pih-LIM-yoo-mab)

 A monoclonal antibody being studied in the treatment of certain types of cancer. Ipilimumab is made in the laboratory and binds to the molecule CTLA-4 on T cells (a type of white blood cell). Ipilimumab may block CTLA-4 and help the immune system kill cancer cells. Also called MDX-010.

Previous Definitions:ionizing radiation, ionomycin, IORT, IP, IP6
Next Definitions:ipsilateral, IRB, Iressa, irinotecan, iris